PIII · P3 Health Partners Inc.
$10.69
-0.27 (-2.46%)
At close · Aug 14
Going-concern doubt
— flagged Aug 10, 2026
Substantial doubt about the company's ability to continue as a going concern.
“As a result of these matters, substantial doubt exists about the Company's ability to continue as a going concern for one year after the date the financial statements are issued.”View the 10-Q filed Aug 10, 2026
Market Cap
$77.58M
Shares
7.26M
P3 Health Partners Inc. Earnings Call Transcripts
Every quarterly earnings call for P3 Health Partners Inc. (PIII) — the full transcript with speaker labels, the audio replay, AI call highlights and a management-tone score, plus the matching 8-K earnings release and the quarter's 10-Q or 10-K. Investor days and conferences appear here too.
Revenue & result across quarters
Revenue Net income YoY up YoY down artefacts
▲59%
$248.26M
−$11.17M
'22 Q3
22-10-20
·
$258.21M
−$94.03M
'22 Q4
23-01-11
▲10.4%
$302.08M
−$9.20M
'23 Q1
23-05-10
▲22.1%
$329.09M
−$9.82M
'23 Q2
23-08-07
▲16.1%
$288.35M
−$13.30M
'23 Q3
23-11-08
▲34.3%
$346.86M
−$25.46M
'23 Q4
24-01-10
▲28.6%
$388.49M
−$18.70M
'24 Q1
24-05-08
▲15.2%
$379.16M
−$12.02M
'24 Q2
24-08-07
▲25.6%
$362.12M
−$46.51M
'24 Q3
24-11-12
▲6.9%
$370.69M
−$58.62M
'24 Q4
25-03-27
▼3.9%
$373.23M
−$20.48M
'25 Q1
25-05-15
▼6.2%
$355.79M
−$20.36M
'25 Q2
25-08-14
▼4.7%
$345.25M
−$31.59M
'25 Q3
25-11-14
▲3.8%
$384.81M
−$75.52M
'25 Q4
26-03-26
▲3.5%
$386.39M
$1.22M
'26 Q1
26-05-14
LATEST
▲8.6%
$386.38M
$7.44M
'26 Q2
26-08-10
Earnings call
FY26 · Q2
2026-08-10
P3 Health Partners Inc. Q2 FY2026 Earnings Call
Confident tone
Adjusted EBITDA and financial performance
Medical cost trend and utilization management
Guidance and back-half outlook
Revenue
$386.38M
▲ 8.6% YoY Diluted EPS
$-0.63
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Annual General Meeting
Investor event
2026-06-09
2026 Annual Meeting of Stockholders
No reported result — non-financial event
Audio
Transcript
Slides
Earnings call
FY26 · Q1
2026-05-14
P3 Health Partners Inc. Q1 FY2026 Earnings Call
Confident tone
Medical cost trend management
Payer contract restructuring and delegation
Adjusted EBITDA outperformance and raised outlook
Revenue
$386.39M
▲ 3.5% YoY Diluted EPS
$0.32
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q4
2026-03-26
P3 Health Partners Inc. Q4 FY2025 Earnings Call
Revenue
$384.81M*
▲ 3.8% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY25 · Q3
2025-11-14
P3 Health Partners Inc. Q3 FY2025 Earnings Call
Cautious tone
Operational stabilization and EBITDA expansion opportunity
Revised guidance and prior-period adjustments
2026 rate environment and revenue outlook
Revenue
$345.25M
▼ 4.7% YoY Diluted EPS
$-9.67
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q2
2025-08-14
P3 Health Partners Inc. Q2 FY2025 Earnings Call
Positive tone
2026 opportunity and base rate increase
EBITDA improvement plan and profitability trajectory
Care enablement model and clinical programs
Revenue
$355.79M
▼ 6.2% YoY Diluted EPS
$-6.23
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q1
2025-05-15
P3 Health Partners Inc. Q1 FY2025 Earnings Call
Positive tone
2025 Guidance Reiteration
Membership and Network Rationalization
Per Member Funding and Risk Adjustment
Revenue
$373.23M
▼ 3.9% YoY Diluted EPS
$-6.28
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q4
2025-03-27
P3 Health Partners Inc. Q4 FY2024 Earnings Call
Revenue
$370.69M*
▲ 6.9% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY24 · Q3
2024-11-12
P3 Health Partners Inc. Q3 FY2024 Earnings Call
Positive tone
Medicare Advantage Sector Headwinds
Value-Based Care Platform and Demand
Initiatives to Drive Profitability
Revenue
$362.12M
▲ 25.6% YoY Diluted EPS
$-15.70
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q2
2024-08-07
P3 Health Partners Inc. Q2 FY2024 Earnings Call
Positive tone
Financial performance and guidance
Medicare Advantage / value-based care market opportunity
Growth in ACO Reach
Revenue
$379.16M
▲ 15.2% YoY Diluted EPS
$-7.37
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q1
2024-05-08
P3 Health Partners Inc. Q1 FY2024 Earnings Call
Positive tone
Persistency and renewal
ACO REACH expansion
Adjusted EBITDA and profitability path
Revenue
$388.49M
▲ 28.6% YoY Diluted EPS
$-7.86
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q4
2024-01-10
P3 Health Partners Inc. Q4 FY2023 Earnings Call
Confident tone
Medical Margin and Utilization
Membership and Growth
Q4 2023 Miss and Reserve Adjustment
Revenue
$346.86M*
▲ 34.3% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY23 · Q3
2023-11-08
P3 Health Partners Inc. Q3 FY2023 Earnings Call
Revenue
$288.35M
▲ 16.1% YoY Diluted EPS
$-6.00
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q2
2023-08-07
P3 Health Partners Inc. Q2 FY2023 Earnings Call
Revenue
$329.09M
▲ 22.1% YoY Diluted EPS
$-4.50
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q1
2023-05-10
P3 Health Partners Inc. Q1 FY2023 Earnings Call
Revenue
$302.08M
▲ 10.4% YoY Diluted EPS
$-11.00
Rev · 7q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q4
2023-01-11
P3 Health Partners Inc. Q4 FY2022 Earnings Call
Revenue
$258.21M*
Rev · 6q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY22 · Q3
2022-10-20
P3 Health Partners Inc. Q3 FY2022 Earnings Call
Revenue
$248.26M
▲ 59% YoY Diluted EPS
$-13.50
Rev · 6q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q2
2022-06-30
P3 Health Partners Inc. Q2 FY2022 Earnings Call
Revenue
$269.45M
▲ 86.4% YoY Diluted EPS
$-186.50
Rev · 5q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q1
2022-04-14
P3 Health Partners Inc. Q1 FY2022 Earnings Call
Revenue
$273.54M
▲ 80.8% YoY Diluted EPS
$-12.50
Rev · 4q
Audio
Transcript
Slides
8-K10-Q
Showing 1–19 of 19 earnings calls
Key facts
CIK
1832511
CUSIP
744413204
13F (30d)
34 filings
34 filers
Visit website
Investor relations